The developers of AstraZeneca’s coronavirus vaccine say the shot appears to work against the variant detected in Britain late last year.

New research suggests Pfizer’s COVID-19 vaccine can protect against a mutation found in the two more-contagious variants of the coronavirus that have erupted in Britain and South Africa.

Despite a number of mutations so far of SARS-CoV-2 virus, the culprit behind the ongoing COVID-19 pandemic, none of them, including the latest UK variant, has made a significant impact on the susceptibility of the virus to any of the currently used therapeutics, drugs or the vaccines under development, experts from the World Health Organization (WHO) have said.